/
Cardiovascular
Stroke
196
Pipeline Programs↗
580
Active Trials↗
175
Companies Involved↗
Stroke is a highly competitive landscape with 196 programs across 175 companies. The most active players are Roche, Biogen. 52 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical105
Phase 110
Phase 229
Phase 352
Approved
No programs
Analysis
Modality Breakdown
88%
Small molecule
147 of 168 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 168 classified programs, each share of the total. Modality classified for 95% of 196 pipeline programs.
Analysis
Trial Status
1,508
clinical trials
Completed573 · 38%
Recruiting352 · 23%
Unknown status198 · 13%
Not yet recruiting165 · 11%
Terminated96 · 6%
Active, not recruiting50 · 3%
Other74 · 5%
Clinical Trials
Trial Activity
1508 trials
Rehabilitation of Unilateral Spatial Neglect Using an Immersive Virtual Reality Music Practice Program
Recruiting·—·Preclinical·NCT06366360·80 enrolled
Understanding Stroke Outcomes: Stroke Resilience, Infarct Burden, and Long-Term Cognition
Recruiting·National Institute of Neurological Disorders and Stroke (NINDS)·N/A·NCT06615973·450 enrolled
Rescue Endovascular Treatment After Neurological Deterioration in Initially Mild Basilar Artery Occlusion in an Extended Time Window
Recruiting·FFirst Affiliated Hospital of Wannan Medical College·Preclinical·NCT06843356·159 enrolled
Page 1 of 101
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)